EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Ritonavir: How the Discovery of a New Polymorph Changed Drug Development Forever
AIDS is a chronic illness that gained global attention in the s It weakens the immune system of the body making it hard to fight infections When HIV enters the body it targets CD Tcells a type of white blood cell that helps defend against diseases It uses the machinery of Tcells to make new copies of the virus due to which the immune cells are destroyed As the virus spreads and the number of healt...
Biosimilars in Europe: Expanding Access and Reducing Costs
The use of biosimilars as a part of modern health care systems is also fairly important especially in the context of the European Union as they can enhance the availability of the required treatments and reduce the costs of the health care sector As biologic medicines are recognized as firstline treatments for critical illnesses such as cancer autoimmune diseases and rheumatoid arthritis biosimila...
How Drug Patents Shape the Competitive Landscape in Pharma?
It can rightly be said that the business of pharmaceuticals is very sensitive and crucial since business is all about the manufacturing of change for the purpose of ridding the world of diseases
The Next Growth Strategy: Scaling GLP-1 Manufacturing and Global Market Expansion
For most of the past four years the strategic conversation around GLP receptor agonists was a demand story Prescriptions outran forecasts waiting lists formed pharmacy shelves emptied and the commercial debate centred on reimbursement prescriber behaviour and how far the obesity indication could stretch That conversation has changed Demand for incretin therapies is now the most predictable variabl...
The Architect of the Void: When 3D Printing Becomes the Body’s New Bone
In the quiet pressurised hum of a modern surgical suite a surgeon holds a highdefinition scan of a young patients femur On the screen a jagged dark shadow marks where an osteosarcoma has claimed its territory For decades the script for this moment has been written in cold hard steel
Global CDMO Expansion: Supporting the Growing Advanced Therapy Pipeline
The European advanced therapy sector has spent the better part of two decades proving a scientific point that engineered cells corrected genes and reprogrammed immune systems can deliver durable clinical benefit That argument is now largely settled The question facing pharmaceutical and biotech leadership is industrial rather than scientific whether these therapies can be manufactured consistentl...
-
Techno Trends
Juniper Biosciences Secures FDA Breakthrough Designation
The US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to Juniper Biosciences JBS Ffluoromisonidazole or FMISO for identifying tumour hypoxia in patients with HPVpositive oropharyngeal carcinoma OPC
-
Projects
Onyx Scientific to Invest Over US$2 Million (£1.5 Million) in Sunderland GMP Facility Expansion
Onyx Scientific is investing more than US Million Million to expand its Good Manufacturing Practice GMP facilities at its Sunderland UK site The investment will increase capacity for commercial
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Biosimilars in Europe: Expanding Access and Reducing Costs
Kate Williamson
Biosimilars are indeed cheaper versions of original biologic drugs and have been embraced the European countries as a strategy to making available affordable lifesaving treatments while at the same ti...
-
2
How Drug Patents Shape the Competitive Landscape in Pharma?
Kate Williamson
Drug patents are central in the pharmaceutical field because they offer marketing privileges over drugs, foster technological advancement, and control the market. They drive the research expenditure,...
-
3
The Next Growth Strategy: Scaling GLP-1 Manufacturing and Global Market Expansion
Lakshmi
Incretin medicines have moved from a supply crisis into a scale contest. For European pharmaceutical and biotech leaders, growth in this class now rests on industrial decisions: synthesis route, purif...
-
4
The Architect of the Void: When 3D Printing Becomes the Body’s New Bone
Baher A. Daihom
This article explores the transformative role of 3D bioprinting in treating bone cancer. By integrating patient-specific scaffolds with localised, time-released chemotherapy and osteoinductive bio-ink...
-
5
Global CDMO Expansion: Supporting the Growing Advanced Therapy Pipeline
Lakshmi
Europe's advanced therapy pipeline is maturing faster than the manufacturing base built to serve it. This article examines how global CDMO expansion is redrawing capacity, cost and control for cel...
press releases Read more...
Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Alkermes plc Nasdaq ALKS today announced positive topline results from a phase proofofconcept study evaluating ALKS the companys novel investigational orexin receptor OXR agonist in development
Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform
Precigen Inc Nasdaq PGEN a commercialstage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients
Amneal Announces FDA Approval and Launch of Lanreotide Injection
Amneal Pharmaceuticals Inc Amneal or the Company NASDAQ AMRX today announced that the US Food and Drug Administration FDA has approved its lanreotide injection mg mL in a sterile
Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer
Nuvation Bio Inc NYSE NUVB a global oncology company focused on tackling some of the toughest challenges in cancer treatment today announced that the US Food and Drug Administration FDA
Events Read more...
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
LATEST NEWS Read more...
PTC Completes Acquisition of ST-920 Gene Therapy for Fabry Disease
PTC Therapeutics has completed its previously announced agreement with Sangamo Therapeutics to acquire ST isaralgagene civaparvovec a onetime AAV gene therapy candidate being developed for Fabry disease
Made Scientific Expands U.S. GMP Cell Therapy Network with Pennsylvania Acquisition
Made Scientific has acquired an sq ft cell therapy manufacturing facility in East Norriton Pennsylvania from National Resilience The transaction was completed on September expanding
BioCytics and Eremid collaborate on single-cell sequencing study for cancer cell therapy
BioCytics Inc has engaged Eremid Genomic Services to sequence an autologous immune cell fraction being developed for its immunebased cancer cell therapy programme
MAbxience and Sandoz collaborate to advance global access to emicizumab biosimilar
MAbxience majorityowned by Fresenius SE Co KGaA with partial ownership from Insud Pharma has entered into a licensing development manufacturing and commercialisation agreement with Sandoz for an emicizumab
Orbis Medicines enters multi-target drug discovery partnership with Novo Nordisk
Orbis Medicines has entered a strategic collaboration and licence agreement with Novo Nordisk to discover and develop nextgeneration oral macrocycle medicines for cardiometabolic diseases
Everest Clinical Research expands global biometrics capabilities with Firma DS acquisition
Everest Clinical Research has acquired the Biometrics and Data Services business unit of Firma Clinical Research expanding its global biometrics expertise and clinical data science capabilities







